Bluestar Adisseo Balance Sheet Health

Financial Health criteria checks 5/6

Bluestar Adisseo has a total shareholder equity of CN¥15.9B and total debt of CN¥1.2B, which brings its debt-to-equity ratio to 7.4%. Its total assets and total liabilities are CN¥22.3B and CN¥6.4B respectively. Bluestar Adisseo's EBIT is CN¥1.8B making its interest coverage ratio 28.8. It has cash and short-term investments of CN¥1.3B.

Key information

7.4%

Debt to equity ratio

CN¥1.17b

Debt

Interest coverage ratio	28.8x
Cash	CN¥1.33b
Equity	CN¥15.85b
Total liabilities	CN¥6.42b
Total assets	CN¥22.27b

Recent financial health updates

We Think Bluestar Adisseo (SHSE:600299) Can Manage Its Debt With Ease

Oct 11

Is Bluestar Adisseo (SHSE:600299) A Risky Investment?

Mar 27

Recent updates

Bluestar Adisseo's (SHSE:600299) Returns On Capital Not Reflecting Well On The Business

Apr 25

There May Be Some Bright Spots In Bluestar Adisseo's (SHSE:600299) Earnings

Apr 04

Is Bluestar Adisseo (SHSE:600299) A Risky Investment?

Mar 27

Optimistic Investors Push Bluestar Adisseo Company (SHSE:600299) Shares Up 25% But Growth Is Lacking

Mar 06

Is There An Opportunity With Bluestar Adisseo Company's (SHSE:600299) 32% Undervaluation?

Feb 28

Financial Position Analysis

Short Term Liabilities: 600299's short term assets (CN¥6.4B) exceed its short term liabilities (CN¥3.6B).

Long Term Liabilities: 600299's short term assets (CN¥6.4B) exceed its long term liabilities (CN¥2.8B).

Debt to Equity History and Analysis

Debt Level: 600299 has more cash than its total debt.

Reducing Debt: 600299's debt to equity ratio has increased from 0.2% to 7.4% over the past 5 years.

Debt Coverage: 600299's debt is well covered by operating cash flow (273.8%).

Interest Coverage: 600299's interest payments on its debt are well covered by EBIT (28.8x coverage).

Bluestar Adisseo Balance Sheet Health

Financial Health criteria checks 5/6

Key information

Recent financial health updates

We Think Bluestar Adisseo (SHSE:600299) Can Manage Its Debt With Ease

Is Bluestar Adisseo (SHSE:600299) A Risky Investment?

Recent updates

Consensus EPS estimates fall by 13%

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

We Think Bluestar Adisseo (SHSE:600299) Can Manage Its Debt With Ease

Bluestar Adisseo Company to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 16%

Bluestar Adisseo (SHSE:600299) Is Finding It Tricky To Allocate Its Capital

Second quarter 2024 earnings: EPS in line with expectations, revenues disappoint

Getting In Cheap On Bluestar Adisseo Company (SHSE:600299) Is Unlikely

Price target increased by 12% to CN¥11.23

Bluestar Adisseo Company to Report First Half, 2024 Results on Aug 30, 2024

Are Investors Undervaluing Bluestar Adisseo Company (SHSE:600299) By 32%?

Bluestar Adisseo Company, Annual General Meeting, Jun 26, 2024

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Bluestar Adisseo Company announced that it expects to receive CNY 3 billion in funding

Bluestar Adisseo's (SHSE:600299) Returns On Capital Not Reflecting Well On The Business

There May Be Some Bright Spots In Bluestar Adisseo's (SHSE:600299) Earnings

Full year 2023 earnings: EPS and revenues miss analyst expectations

Bluestar Adisseo Company to Report Q1, 2024 Results on Apr 26, 2024

Is Bluestar Adisseo (SHSE:600299) A Risky Investment?

Consensus EPS estimates increase by 21%

Optimistic Investors Push Bluestar Adisseo Company (SHSE:600299) Shares Up 25% But Growth Is Lacking

Is There An Opportunity With Bluestar Adisseo Company's (SHSE:600299) 32% Undervaluation?

Bluestar Adisseo Company to Report Fiscal Year 2023 Results on Mar 29, 2024

Consensus EPS estimates increase by 10%, revenue downgraded

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

New minor risk - Earnings quality

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Bluestar Adisseo Company to Report First Half, 2023 Results on Aug 05, 2023

Consensus revenue estimates decrease by 17%

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 7.6% to CN¥11.84

Less than half of directors are independent

Consensus forecasts updated

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment improved over the past week

Price target decreased to CN¥12.76

Consensus EPS estimates fall by 22%

Second quarter 2022 earnings released: EPS: CN¥0.16 (vs CN¥0.16 in 2Q 2021)

Price target decreased to CN¥13.40

Bluestar Adisseo Company, Annual General Meeting, May 16, 2022

First quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Less than half of directors are independent

Bluestar Adisseo Company, Annual General Meeting, Apr 29, 2022

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.14 in 3Q 2020)

Less than half of directors are independent

Price target decreased to CN¥15.11

Second quarter 2021 earnings released: EPS CN¥0.16 (vs CN¥0.16 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.11 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.50 (vs CN¥0.37 in FY 2019)

New 90-day high: CN¥14.80

Investor sentiment improved over the past week

New 90-day low: CN¥11.07

New 90-day low: CN¥11.88

Third quarter earnings released

Third-quarter earnings released: Revenue misses expectations

Bluestar Adisseo Company to Report Q3, 2020 Results on Oct 30, 2020

New 90-day low: CN¥12.50

Bluestar Adisseo Company (SHSE:600299) signed an agreement to acquire FraMelco B.V. from a family.

Bluestar Adisseo Company (SHSE:600299) completed the acquisition remaining 15% stake in Blue Star Adisseo Nutrition Group Co., Ltd. from China National BlueStar (Group) Co., Ltd.

Financial Position Analysis

Debt to Equity History and Analysis

Balance Sheet

Discover healthy companies